GHTF (Global Harmonization Task Force) takesstock of its strategic direction
This article was originally published in Clinica
How has the Global Harmonization Task Force performed to date? That is a question that Maurice Wagner, its vice-chairman, will put to a panel at the GHTF meeting in Lubeck, Germany, next week (June 28-30). Mr Wagner, who is also director general of the European medtech industry association, Eucomed, told Clinica during a recent interview in Brussels that he wishes to check that the process is worth the investment and to see if any further changes should be made.
You may also be interested in...
ConMed's CFO Todd Garner told delegates at the Jefferies Healthcare conference that the company's orthopedic franchise is focused on its pipeline and meeting customer's needs. See what the CFO said about it here.
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.